Study | Age (years) | Sex | Tumor site | Tumor histology | Other malignancies | MMR loss (IHC) | MSI | MMR germline variant |
---|---|---|---|---|---|---|---|---|
Lee et al. [10] | 58 | M | Retroperitoneum | Undifferentiated pleomorphic sarcoma | Colon, Sebaceous neoplasm | MSH2 | MSI-H | MSH2 (not specified) |
Yozu et al. [5] | 74 | M | Buttock | Pleomorphic liposarcoma | Colon, Sebaceous neoplasm, Prostate | MSH2/MSH6 | NA | MSH2 (not specified) |
Latham et al. [9] | 71 | NA | NA | Soft tissue sarcoma | Colon, Endometrial, Sebaceous adenoma | MSH2/MSH6 | MSI-H | MSH2 (c.1216 C > T, p.Arg406Ter) |
de Angelis de Carvalho et al. [11] | 40 | F | NA | Osteosarcoma | Sebaceoma | MSH2/MSH6 | MSI-H | MSH2 (c.1661 + 1G > A, p.Gly504Alafs*3) |
51 | M | NA | Soft tissue sarcoma | Colon, Sebaceoma | MSH2/MSH6 | NA | MSH2 (c.1444 A > T, p.Arg482Ter) | |
Present case | 73 | M | Abdominal wall | Myxofibrosarcoma | Colon, Duodenal, Pancreas, sebaceous epithelioma | MLH1/PMS2 | MSI-H | MLH1 (c.1233_1254dup22, p.Ile412CysfsTer5) |